# Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin

> **NCT00411190** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 32 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Relacatib
- **DRUG:** Acetaminophen
- **DRUG:** Ibuprofen
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00411190
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-19
- **Primary completion:** 2006-12-15
- **Final completion:** 2006-12-15
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411190, "Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00411190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*